COVID-19, virus identified. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Doxycycline capsules are given orally made by Iran Daru Company (Iran) 100 mg twice a day for 10 days along with standard care and medication measures for Covid pat
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Minimum age 18 and maximum age 80 years Do not take doxycycline for the last five days Patients with definitive diagnosis of Covid 19 (RT-PCR) candidate for outpatient treatment with pulmonary involvement score on CT scan equal to or below 8 Patients suspected of Covid-19 based on clinical signs and manifestations of CT scan and laboratory results candidate for outpatient treatment.
Exclusion criteria
Exclusion criteria: Hospitalization Patients with no indications for outpatient treatment based on national protocol. pregnancy Patients with a history of allergic reaction or Doxycycline. Underlying disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of clinical symptoms. Timepoint: Start of study and 3, 7, 14 days after study. Method of measurement: Questionnaire - telephone follow-up and.;Hospitalizations. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up.;Mortality rate. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of doxycycline. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Sadeghibidar
Hamedan University of Medical Sciences
Outcome results
None listed